Advancements in Red Blood Cell Detection using Convolutional Neural Networks

Author(s):  
František Kajánek ◽  
Ivan Cimrák
2020 ◽  
Vol 28 (22) ◽  
pp. 33504 ◽  
Author(s):  
Timothy O’Connor ◽  
Christopher Hawxhurst ◽  
Leslie M. Shor ◽  
Bahram Javidi

Author(s):  
Angel Molina ◽  
José Rodellar ◽  
Laura Boldú ◽  
Andrea Acevedo ◽  
Santiago Alférez ◽  
...  

2018 ◽  
Vol 21 (6) ◽  
pp. 1721-1743 ◽  
Author(s):  
Xipeng Pan ◽  
Dengxian Yang ◽  
Lingqiao Li ◽  
Zhenbing Liu ◽  
Huihua Yang ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Konobu Kimura ◽  
Yoko Tabe ◽  
Tomohiko Ai ◽  
Ikki Takehara ◽  
Hiroshi Fukuda ◽  
...  

Abstract Detection of dysmorphic cells in peripheral blood (PB) smears is essential in diagnostic screening of hematological diseases. Myelodysplastic syndromes (MDS) are hematopoietic neoplasms characterized by dysplastic and ineffective hematopoiesis, which diagnosis is mainly based on morphological findings of PB and bone marrow. We developed an automated diagnostic support system of MDS by combining an automated blood cell image-recognition system using a deep learning system (DLS) powered by convolutional neural networks (CNNs) with a decision-making system using extreme gradient boosting (XGBoost). The DLS of blood cell image-recognition has been trained using datasets consisting of 695,030 blood cell images taken from 3,261 PB smears including hematopoietic malignancies. The DLS simultaneously classified 17 blood cell types and 97 morphological features of such cells with >93.5% sensitivity and >96.0% specificity. The automated MDS diagnostic system successfully differentiated MDS from aplastic anemia (AA) with high accuracy; 96.2% of sensitivity and 100% of specificity (AUC 0.990). This is the first CNN-based automated initial diagnostic system for MDS using PB smears, which is applicable to develop new automated diagnostic systems for various hematological disorders.


Sign in / Sign up

Export Citation Format

Share Document